For patients with serious ailments—ranging from cancerto autoimmune diseases—access to cell therapies can mean the difference between life and death. But since cell therapies are created for each patient individually, they’re incredibly difficult to scale. As a result, demand greatly outstrips supply, meaning thousands of people around the world can’t access these crucial treatments.
Enter Cellares,
